Andrew Slade

Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, <i>In Vitro</i> and <i>In Vivo</i> in p53 Functional and Dysfunctional Models of Human Cancer

Michael A. Batey, Yan Zhao, Suzanne Kyle et al. · Molecular Cancer Therapeutics · 2013 · 156 citations · Full text

Atm Inhibition, Oncology, Preclinical Evaluation +15

Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K

Joanne M. Munck, Michael A. Batey, Yan Zhao et al. · Molecular Cancer Therapeutics · 2012 · 128 citations · Full text

Dual Inhibitor, Tumor Biology, Dna Double-strand Breaks +15

Phase I Study of MetXia-P450 Gene Therapy and Oral Cyclophosphamide for Patients with Advanced Breast Cancer or Melanoma

Jeremy Braybrooke, Andrew Slade, G. Deplanque et al. · Clinical Cancer Research · 2005 · 98 citations

Discriminant Effectiveness of Psychological State Measures in Predicting Performance Outcome in Karate Competition

Peter C. Terry, Andrew Slade · Perceptual and Motor Skills · 1995 · 97 citations

Behavioral Sciences, Discriminant Function Analysis, High-performance Sport +15

Population Sequence Analysis of a Simian Immunodeficiency Virus (32H Reisolate of SIV _mac251 ): A Virus Stock Used for International Vaccine Studies

Neil Almond, Adrian Jenkins, Andrew Slade et al. · AIDS Research and Human Retroviruses · 1992 · 49 citations